Av Vania Morelli
Forsker ved TREC
Anticoagulants, commonly referred to as blood thinners, are drugs used to prevent the
formation of blood clots in the blood vessels or in the heart. A new generation of drugs, the so-called direct oral anticoagulants (DOACs), has emerged as an interesting alternative to warfarin, a well-known anticoagulant by clinicians, for oral anticoagulation. A new study searched for a therapeutic strategy to manage life-threatening bleeding in patients who use DOACs.
